MUSC Hollings Cancer Center Clinical Trials

Health Service Research Trials

Every treatment that has ever made a difference in cancer care was once a part of a clinical trial. MUSC Hollings Cancer Center is committed to offering the best treatments available today while searching for even better ones for the future. Ask your doctor if a clinical trial is right for you.

STUDY27022

Evaluating the Impact of TrialTalk™ to Foster Equitable Cancer Care Delivery and Clinical Trial Participation

Examine TrialTalk effectiveness by examining the changes in clinical tiral accrual from baseline by race and ethnicity among enrolled providers and at the institution level up to 12 months post- implementation. Examine the implementation outcomes of TrialTalk such as adoption, penetration, fidelity, feasibility, and acceptability with different stakeholder groups.

Study Information

STUDY27070

E-Care Breast Cancer Risk Assessment Study

Risk-stratified breast cancer screening is recommended by evidence-based guidelines but not systematically implemented within primary care clinics, The study objective is to evaluate the acceptability and feasibility of implementation of the E-care intervention. Our hypothesis is that greater than 80% of patients will report that the E-CARE intervention is both feasible and acceptable. Secondary objectives include to evaluate the informed decision making in breast cancer screening and risk-aligned screening.